A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer.
Houédé N, Pulido M, Mourey L, Joly F, Ferrero JM, Bellera C, Priou F, Lalet C, Laroche-Clary A, Raffin MC, Ichas F, Puech A, Piazza PV.
Houédé N, et al. Among authors: ichas f.
Oncologist. 2014 Dec;19(12):1227-8. doi: 10.1634/theoncologist.2014-0345. Epub 2014 Oct 29.
Oncologist. 2014.
PMID: 25355844
Free PMC article.
Clinical Trial.